Top compounds associated with response to IFFO2


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA silmitasertib CTRPv2 pan-cancer AAC -0.032 0.4
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.041 0.4
mRNA Docetaxel gCSI pan-cancer AAC 0.05 0.4
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA ciclosporin CTRPv2 pan-cancer AAC -0.03 0.4
mRNA Compound 1541A CTRPv2 pan-cancer AAC -0.031 0.4
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.037 0.4
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC 0.03 0.5
Download CSV